SC-25 A Multi-Center, Open-Label, Long-Term Study of OraVescent Fentanyl Citrate for the Treatment of Breakthrough Pain in Opioid-Tolerant Cancer Patients

  • PASSIK, STEVEN (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date7/19/04 → 2/11/05